D. E. Shaw & Co., Inc. Soma Logic, Inc. Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.99 - $2.45 $112,166 - $138,094	-56,365 Reduced 49.77%	56,883 $135,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $3.36 $197,103 - $315,366	-93,859 Reduced 45.32%	113,248 $261,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $392,631 - $663,602	-184,334 Reduced 47.09%	207,107 $528,000
Q4 2022 Feb 14, 2023	SELL	$2.05 - $3.47 $181,970 - $308,018	-88,766 Reduced 18.48%	391,441 $982,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $109,003 - $946,430	173,022 Added 56.33%	480,207 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $822,120 - $1.59 Million	192,534 Added 167.93%	307,185 $1.39 Million
Q1 2022 May 16, 2022	SELL	$7.07 - $11.62 $1.17 Million - $1.92 Million	-165,375 Reduced 59.06%	114,651 $920,000
Q4 2021 Feb 14, 2022	SELL	$10.49 - $14.28 $11 Million - $15 Million	-1,052,336 Reduced 78.98%	280,026 $3.26 Million
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $13.2 Million - $17 Million	1,332,362 New	1,332,362 $16.5 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.